IL285805A - Quinazolinone compounds, compositions comprising same and uses thereof - Google Patents
Quinazolinone compounds, compositions comprising same and uses thereofInfo
- Publication number
- IL285805A IL285805A IL285805A IL28580521A IL285805A IL 285805 A IL285805 A IL 285805A IL 285805 A IL285805 A IL 285805A IL 28580521 A IL28580521 A IL 28580521A IL 285805 A IL285805 A IL 285805A
- Authority
- IL
- Israel
- Prior art keywords
- preparations containing
- quinazolinone compounds
- quinazolinone
- compounds
- preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962811471P | 2019-02-27 | 2019-02-27 | |
| PCT/US2020/019942 WO2020176652A1 (en) | 2019-02-27 | 2020-02-26 | Quinazolinone compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL285805A true IL285805A (en) | 2021-10-31 |
Family
ID=72238692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL285805A IL285805A (en) | 2019-02-27 | 2021-08-23 | Quinazolinone compounds, compositions comprising same and uses thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12454514B2 (https=) |
| EP (1) | EP3930837A4 (https=) |
| JP (1) | JP7597722B2 (https=) |
| KR (1) | KR20210139279A (https=) |
| CN (1) | CN113747943A (https=) |
| AU (1) | AU2020228374A1 (https=) |
| CA (1) | CA3131294A1 (https=) |
| IL (1) | IL285805A (https=) |
| WO (1) | WO2020176652A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024033374A1 (en) | 2022-08-11 | 2024-02-15 | Syngenta Crop Protection Ag | Novel arylcarboxamide or arylthioamide compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07107056B2 (ja) * | 1987-01-30 | 1995-11-15 | 日清製粉株式会社 | ４（３ｈ）−キナゾリノン誘導体、その製造方法およびそれを有効成分とする抗潰瘍剤 |
| US7381730B2 (en) * | 2002-03-15 | 2008-06-03 | Bristol-Myers Squibb Company | 3-arylquinazoline derivatives as selective estrogen receptor beta modulators |
| US20050038051A1 (en) * | 2003-06-09 | 2005-02-17 | Jodi Nunnari | Novel molecules for regulating cell death |
| US9492450B2 (en) * | 2011-04-19 | 2016-11-15 | University of Pittsburgh—of the Commonwealth System of Higher Education | Inhibition of dynamin related protein 1 to promote cell death |
| WO2013025508A1 (en) * | 2011-08-12 | 2013-02-21 | Southern Research Institute | Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections |
| JP2013142070A (ja) | 2012-01-11 | 2013-07-22 | Nihon Univ | ミトコンドリア分裂阻害剤を用いたｔｒａｉｌ抵抗性の克服 |
| CN111372921B (zh) * | 2017-09-13 | 2023-12-01 | 赛勒佩特公司 | 小分子化合物 |
| US11559527B2 (en) | 2017-12-20 | 2023-01-24 | Lunella Biotech, Inc. | Targeting mitochondrial fission through mDIVI-1 derivatives |
| US20190307749A1 (en) * | 2018-04-10 | 2019-10-10 | Texas Tech University System | Mitochondria-Division Inhibitor 1 Protects Against Amyloid-B Induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease |
-
2020
- 2020-02-26 KR KR1020217030721A patent/KR20210139279A/ko active Pending
- 2020-02-26 WO PCT/US2020/019942 patent/WO2020176652A1/en not_active Ceased
- 2020-02-26 CA CA3131294A patent/CA3131294A1/en active Pending
- 2020-02-26 EP EP20763727.3A patent/EP3930837A4/en active Pending
- 2020-02-26 JP JP2021549941A patent/JP7597722B2/ja active Active
- 2020-02-26 US US17/434,145 patent/US12454514B2/en active Active
- 2020-02-26 CN CN202080030788.4A patent/CN113747943A/zh active Pending
- 2020-02-26 AU AU2020228374A patent/AU2020228374A1/en not_active Abandoned
-
2021
- 2021-08-23 IL IL285805A patent/IL285805A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20220162172A1 (en) | 2022-05-26 |
| US12454514B2 (en) | 2025-10-28 |
| AU2020228374A1 (en) | 2021-09-23 |
| WO2020176652A1 (en) | 2020-09-03 |
| EP3930837A4 (en) | 2022-10-05 |
| KR20210139279A (ko) | 2021-11-22 |
| JP2022523383A (ja) | 2022-04-22 |
| CN113747943A (zh) | 2021-12-03 |
| JP7597722B2 (ja) | 2024-12-10 |
| CA3131294A1 (en) | 2020-09-03 |
| EP3930837A1 (en) | 2022-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288104A (en) | Heterocyclic compounds, preparation methods and uses thereof | |
| IL279897A (en) | Fusosome compositions and uses thereof | |
| IL272089A (en) | Compounds, compositions and methods | |
| IL285178A (en) | Compounds and uses thereof | |
| IL286693A (en) | Modulator compounds of the integrated stress pathway, compositions comprising same and uses thereof | |
| IL284835A (en) | Pharmaceutical combination comprising tno155 and ribociclib | |
| IL263437B (en) | -'5 cyclo-phosphonate modified nucleotides, compositions comprising same and uses thereof | |
| IL289997A (en) | Fungicidal combinations, mixtures and compositions and uses thereof | |
| HUE053737T2 (hu) | Piridopirrolokinoxalin vegyületek, készítményeik és alkalmazásaik | |
| IL285461A (en) | Processes and compounds | |
| IL282998A (en) | Pyridazinone compounds and uses thereof | |
| PL3505535T3 (pl) | Przeciwciało monoklonalne anty-pd1, jego kompozycja farmaceutyczna i jego zastosowanie | |
| IL280317A (en) | Anti-avb8 antibodies and compositions and uses thereof | |
| EP3633034A4 (en) | MODIFIED Cas9 PROTEIN AND USE THEREOF | |
| IL278122B1 (en) | Pteridinone compounds and uses thereof | |
| IL284878A (en) | Trem compositions and uses thereof | |
| IL279537A (en) | Aav compositions | |
| HUE061963T2 (hu) | Karbamid-vegyületek és készítmények mint SMARCA2/BRM-ATPáz gátlók | |
| IL263574A (en) | Calr and jak2 vaccine compositions | |
| IL292961A (en) | Cyclooctatetraene containing dyes and compositions | |
| IL277171A (en) | Herbicidal compounds | |
| HUE055762T2 (hu) | Nyújtott hatású készítmények | |
| IL285118A (en) | Compounds and uses thereof | |
| IL289819A (en) | Benzenesulfonamide derivatives and uses thereof | |
| IL284514A (en) | Halo-allylamine compounds and use thereof |